• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于药效团建模、对接和主成分分析的聚类:用于鉴定人鼻病毒衣壳蛋白新抑制剂的联合计算机辅助方法

Pharmacophore modeling, docking, and principal component analysis based clustering: combined computer-assisted approaches to identify new inhibitors of the human rhinovirus coat protein.

作者信息

Steindl Theodora M, Crump Carolyn E, Hayden Frederick G, Langer Thierry

机构信息

Department of Pharmaceutical Chemistry, Institute of Pharmacy, and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 52c, A-6020 Innsbruck, Austria.

出版信息

J Med Chem. 2005 Oct 6;48(20):6250-60. doi: 10.1021/jm050343d.

DOI:10.1021/jm050343d
PMID:16190752
Abstract

The development and application of a sophisticated virtual screening and selection protocol to identify potential, novel inhibitors of the human rhinovirus coat protein employing various computer-assisted strategies are described. A large commercially available database of compounds was screened using a highly selective, structure-based pharmacophore model generated with the program Catalyst. A docking study and a principal component analysis were carried out within the software package Cerius and served to validate and further refine the obtained results. These combined efforts led to the selection of six candidate structures, for which in vitro anti-rhinoviral activity could be shown in a biological assay.

摘要

本文描述了一种先进的虚拟筛选和选择方案的开发与应用,该方案采用各种计算机辅助策略来鉴定人鼻病毒衣壳蛋白潜在的新型抑制剂。使用由Catalyst程序生成的高选择性、基于结构的药效团模型,对一个大型的市售化合物数据库进行了筛选。在Cerius软件包中进行了对接研究和主成分分析,以验证并进一步优化所得结果。这些综合努力促成了六种候选结构的选择,在生物学试验中已证明它们具有体外抗鼻病毒活性。

相似文献

1
Pharmacophore modeling, docking, and principal component analysis based clustering: combined computer-assisted approaches to identify new inhibitors of the human rhinovirus coat protein.基于药效团建模、对接和主成分分析的聚类:用于鉴定人鼻病毒衣壳蛋白新抑制剂的联合计算机辅助方法
J Med Chem. 2005 Oct 6;48(20):6250-60. doi: 10.1021/jm050343d.
2
Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein.基于结构的虚拟筛选以发现人鼻病毒衣壳蛋白的天然抑制剂
J Med Chem. 2008 Feb 28;51(4):842-51. doi: 10.1021/jm701494b. Epub 2008 Feb 5.
3
Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors.基于药效团的新型氯代哒嗪哌嗪类人鼻病毒(HRV-3)抑制剂的设计、合成与生物评价。
Bioorg Med Chem Lett. 2011 Feb 1;21(3):1057-9. doi: 10.1016/j.bmcl.2010.12.001. Epub 2010 Dec 7.
4
Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.新型氯哒嗪衍生物作为强效人鼻病毒(HRV)衣壳结合抑制剂的合成与评价
Bioorg Med Chem. 2009 Jan 15;17(2):621-4. doi: 10.1016/j.bmc.2008.11.061. Epub 2008 Dec 3.
5
Human rhinovirus 3C protease: generation of pharmacophore models for peptidic and nonpeptidic inhibitors and their application in virtual screening.人鼻病毒3C蛋白酶:肽类和非肽类抑制剂药效团模型的构建及其在虚拟筛选中的应用
J Chem Inf Model. 2005 May-Jun;45(3):716-24. doi: 10.1021/ci049638a.
6
Parallel screening: a novel concept in pharmacophore modeling and virtual screening.并行筛选:药效团建模与虚拟筛选中的一个新概念。
J Chem Inf Model. 2006 Sep-Oct;46(5):2146-57. doi: 10.1021/ci6002043.
7
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.一种具有口服生物利用度的肟醚衣壳结合剂,对人鼻病毒具有强效活性。
J Med Chem. 2003 Jul 17;46(15):3181-4. doi: 10.1021/jm0202876.
8
Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.人凝血因子Xa抑制剂的药效团识别、计算机筛选及虚拟文库设计
J Chem Inf Model. 2005 Jan-Feb;45(1):146-59. doi: 10.1021/ci049778k.
9
Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.运用一些三维定量构效关系技术探索丙型肝炎病毒NS3蛋白酶的P2和P3配体结合特征。
J Mol Graph Model. 2008 Apr;26(7):1131-44. doi: 10.1016/j.jmgm.2007.10.005. Epub 2007 Oct 9.
10
LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.LigandScout:源自与蛋白质结合的配体的三维药效团及其作为虚拟筛选过滤器的用途。
J Chem Inf Model. 2005 Jan-Feb;45(1):160-9. doi: 10.1021/ci049885e.

引用本文的文献

1
Integration of virtual and physical screening.虚拟筛选与实体筛选的整合
Drug Discov Today Technol. 2006 Winter;3(4):377-385. doi: 10.1016/j.ddtec.2006.11.003. Epub 2006 Dec 14.
2
Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an approach of targeted drug designing.选择性芳香植物化学配体阻断SARS-CoV-2 S蛋白与ACE2受体结合的分子优化、对接及动态模拟分析:一种靶向药物设计方法
J Adv Vet Anim Res. 2021 Mar 5;8(1):24-35. doi: 10.5455/javar.2021.h481. eCollection 2021 Mar.
3
Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.
通过计算机模拟分析探究灵芝次生代谢产物的生物学活性
Phytochemistry. 2015 Jun;114:114-24. doi: 10.1016/j.phytochem.2014.10.010. Epub 2014 Nov 6.
4
Study of the biological activity of novel synthetic compounds with antiviral properties against human rhinoviruses.新型具有抗病毒活性的合成化合物对人类鼻病毒的生物学活性研究。
Molecules. 2011 Apr 26;16(5):3479-87. doi: 10.3390/molecules16053479.
5
In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens.基于计算机虚拟筛选的理性配体发现:以芸香的成分研究为例
Planta Med. 2009 Feb;75(3):195-204. doi: 10.1055/s-0028-1088397. Epub 2008 Dec 18.
6
Pharmacophore modeling and parallel screening for PPAR ligands.过氧化物酶体增殖物激活受体(PPAR)配体的药效团模型构建与平行筛选
J Comput Aided Mol Des. 2007 Oct-Nov;21(10-11):575-90. doi: 10.1007/s10822-007-9140-0. Epub 2007 Oct 25.
7
In silico pharmacology for drug discovery: applications to targets and beyond.用于药物发现的计算机模拟药理学:对靶点及其他方面的应用
Br J Pharmacol. 2007 Sep;152(1):21-37. doi: 10.1038/sj.bjp.0707306. Epub 2007 Jun 4.
8
Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.计算机辅助药物发现与开发(CADDD):计算机化学-生物学方法
Chem Biol Interact. 2008 Jan 30;171(2):165-76. doi: 10.1016/j.cbi.2006.12.006. Epub 2006 Dec 16.